Stela received her BSc in Biochemistry and Cell Biology from Jacobs University in Germany and earned her PhD from NYU School of Medicine. Her PhD involved investigating the innate immune response to intestinal viruses using organoids and several mouse models. Stela was a Business Development fellow with NYU’s Technology and Venture office focusing on out-licensing new technology from NYU’s labs. After her PhD, she worked at RTW Investments as an intern focusing on public and private healthcare investing. Stela joined Avoro in 2024 to focus on biotechnology investment opportunities.